You are here: Industry Insights > leukemia

News List

Amgen announces positive results from two Phase 3 BLINCYTO® (blinatumomab) studies In pediatric patients with relapsed acute lymphoblastic leukemia worldpharmanews
September 26, 2019
Amgen announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (20120215) showed that the primary endpoint of event-free survival was met.
Leukemia drug shows promise for treating a childhood brain cancer worldpharmanews
September 25, 2019
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor ...
Medicare to Cover CAR-T Therapy for Leukemia, Lymphoma drugs
August 09, 2019
A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare says.
Drug Duo May Be an Advance Against a Common Leukemia drugs
August 01, 2019
A two-drug combo helps patients with a common form of leukemia survive longer than the current standard of care, a new clinical trial finds.
Syndax Pharma Gets IND Clearance for Leukemia Treatment drugs
July 12, 2019
Will begin Phase 1/2 trial for targeted Menin inhibitor, SNDX-5613, in patients with relapsed/refractory acute leukemias.
Global Patients Whining about the Production Suspension of the Cytarabine Manufacturer PharmaSources/Shanghai Xiaoyaoshi
July 01, 2019
Manufacturing delayed due to the manufacturer’s overhaul; production suspension leading to a shortage in the world
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia En-CPhI.cn
June 24, 2019
Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed
Pediatric CAR T-Cell Immunotherapy Trial Aims to Improve Remission Rates of Leukemia at Children's National Health System firstwordpharma
June 12, 2019
Children's National Health System today announced the opening of a unique chimeric antigen receptor (CAR) T-cell immunotherapy trial for pediatric patients with relapsed positive acute lymphoblastic leukemia (ALL).
AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients drugs
May 22, 2019
AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients.
FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia drugs
May 17, 2019
FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia.

Previous page 1 2 3 4 5 Next page